BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression
BrainswWay Ltd. (NASDAQ & TASE: BWAY), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, announced that it has received 510(k) clearance from the U.S. Food and…
Continue Reading
BrainsWay Receives New FDA Clearance for Treating Depression and Anxious Depression